Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16825323rdf:typepubmed:Citationlld:pubmed
pubmed-article:16825323lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0034833lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0018120lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0221971lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C1571705lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0033559lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0387583lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16825323lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16825323pubmed:issue10lld:pubmed
pubmed-article:16825323pubmed:dateCreated2006-9-18lld:pubmed
pubmed-article:16825323pubmed:abstractTextFollicular production of prostaglandins (PGs) is essential for ovulation, but the factors mediating gonadotropin-induced secretion of PGE and PGF(2alpha) remain largely unknown. We tested the hypothesis that gonadotropin-induced changes in progesterone and its receptor (PR) mediate the increase in periovulatory PGs. Heifers were treated with PGF(2alpha) and GnRH to induce luteolysis and the LH/FSH surge (ovulation occurs approximately 30 h after GnRH). Because there are two increases in intrafollicular progesterone/PR mRNA during the bovine periovulatory period, we first examined the temporal pattern of PG production by follicles collected at 0, 3.5, 6, 12, 18, and 24 h after GnRH. Although PGs did not increase in the follicular fluid until 24 h after GnRH, acute secretion of PGs by follicle wall (theca + granulosa cells) was initiated by 18 h and had increased manyfold by 24 h after GnRH. In vitro, FSH and LH induced dramatic transient increases in PG production by follicle wall and granulosa, but not theca, cells isolated from preovulatory follicles (0 h after GnRH). PG accumulation peaked on d 2 of culture, mimicking the secretion pattern after a gonadotropin surge in vivo. In cultures of follicle wall and granulosa cells, the PR antagonist mifepristone (MIFE, 1 microm) inhibited LH-induced PG secretion and the progestin medroxyprogesterone acetate (1 or 10 microm), but not the glucocorticoid dexamethasone (1 or 10 microm), overcame the effect of MIFE on PGs. Semiquantitative RT-PCR revealed that MIFE inhibited LH-induced expression of cyclooxygenase-2 mRNA in granulosa cells in vitro. Again, treatment with medroxyprogesterone acetate overcame the effect of MIFE. Together these results provide strong evidence that periovulatory increases in cyclooxygenase-2 mRNA, PGE, and PGF(2alpha) are mediated by gonadotropin-induced increases in progesterone/PR, indicating that in some species there is an important functional relationship between these pathways in the ovulatory cascade.lld:pubmed
pubmed-article:16825323pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:languageenglld:pubmed
pubmed-article:16825323pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16825323pubmed:statusMEDLINElld:pubmed
pubmed-article:16825323pubmed:monthOctlld:pubmed
pubmed-article:16825323pubmed:issn0013-7227lld:pubmed
pubmed-article:16825323pubmed:authorpubmed-author:FortuneJ EJElld:pubmed
pubmed-article:16825323pubmed:authorpubmed-author:KomarC MCMlld:pubmed
pubmed-article:16825323pubmed:authorpubmed-author:BridgesP JPJlld:pubmed
pubmed-article:16825323pubmed:issnTypePrintlld:pubmed
pubmed-article:16825323pubmed:volume147lld:pubmed
pubmed-article:16825323pubmed:ownerNLMlld:pubmed
pubmed-article:16825323pubmed:authorsCompleteYlld:pubmed
pubmed-article:16825323pubmed:pagination4713-22lld:pubmed
pubmed-article:16825323pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:meshHeadingpubmed-meshheading:16825323...lld:pubmed
pubmed-article:16825323pubmed:year2006lld:pubmed
pubmed-article:16825323pubmed:articleTitleGonadotropin-induced expression of messenger ribonucleic acid for cyclooxygenase-2 and production of prostaglandins E and F2alpha in bovine preovulatory follicles are regulated by the progesterone receptor.lld:pubmed
pubmed-article:16825323pubmed:affiliationDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853, USA.lld:pubmed
pubmed-article:16825323pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16825323pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:16825323pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16825323pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16825323lld:pubmed